Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Current Assets: 2023-2025

  • Zhengye Biotechnology Holding's Current Assets was N/A to $27.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $27.9 million, marking a year-over-year change of. This contributed to the annual value of $24.3 million for FY2024, which is 9.15% down from last year.
  • According to the latest figures from Q2 2025, Zhengye Biotechnology Holding's Current Assets is $27.9 million, which was up 14.48% from $24.3 million recorded in Q4 2024.
  • In the past 5 years, Zhengye Biotechnology Holding's Current Assets ranged from a high of $27.9 million in Q2 2025 and a low of $24.3 million during Q4 2024.
  • For the 3-year period, Zhengye Biotechnology Holding's Current Assets averaged around $26.2 million, with its median value being $26.3 million (2023).
  • Data for Zhengye Biotechnology Holding's Current Assets shows a maximum YoY dropped of 7.44% (in 2024) over the last 5 years.
  • Over the past 3 years, Zhengye Biotechnology Holding's Current Assets (Quarterly) stood at $26.3 million in 2023, then fell by 7.44% to $24.3 million in 2024, then reached $27.9 million in 2025.
  • Its last three reported values are $27.9 million in Q2 2025, $24.3 million for Q4 2024, and $26.3 million during Q4 2023.